Liz Turner Gillies, Ph.D.,
Scientist, ATCC Cell Systems
Dr. Gillies is a scientist in Cell Biology Research and Development at ATCC. She has more than eight years of experience using CRISPR/Cas9 gene-editing technologies to create advanced tissue culture models and systems. In her current role, she leads a small team developing enhanced bioproduction cell lines, including CRISPR/Cas9-engineered cell lines for enhanced viral vaccine production. She received her Ph.D. in Molecular Biophysics and Biochemistry from Yale in 2015.